What we know
Summary Date Recall was issued:Product Name:Manufacturer:Recalling Firm:Batch(es):Manufacturing Date:Expiry Date:Reason for Recall: 9th January 2025 Shal’Artem (Artemether 180mg and Lumefantrine 1080mg for oral suspension Shalina Laboratories Pvt Limited, India Shalina Healthcare Gh Ltd3390218, 3390154 July 2023, June 2023 June 2026, May 2026 Substandard product, failed assay for Artemether as per the acceptance criteria in the International Pharmacopoeia. AnnouncementThis recall is necessitated as a result of warehouse market surveillance conducted at the warehouse. Actual product specification is a powder for oral suspension. The affected batches were caked and not free flowing. This makes the product substandard and therefore not recommended for its intended use.
Safety advice
- Stop using or purchasing the product if the notice asks you to.
- Keep receipts, batch numbers and packaging — they help with returns or investigations.
- Share this alert with anyone who might be affected, especially relatives and colleagues.
- If you believe you’ve been harmed, contact the official source or a relevant authority.